Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 16
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 16
Join SI Premium – FREE
Roth Capital downgraded Peregrine Pharmaceuticals (NASDAQ: PPHM) from Buy to Neutral.
For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on Peregrine Pharmaceuticals click here.
Shares of Peregrine Pharmaceuticals closed at $1.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Double Downgrades TELUS Corporation (TU) to Underperform
- Oppenheimer Downgrades Walmart (WMT) to Perform
- Truist Securities Downgrades Intuit (INTU) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
